Ramipril: ACE Inhibitor for Blood Pressure and Heart Protection

What is Ramipril?

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor medication used primarily to treat high blood pressure and heart failure. It belongs to a class of drugs that work by blocking the formation of angiotensin II, a hormone that causes blood vessels to narrow. Ramipril is also prescribed to reduce the risk of heart attack, stroke, and cardiovascular death in patients at high risk for these conditions.

Uses

Ramipril is approved for several cardiovascular conditions:

• High blood pressure (hypertension): Used alone or in combination with other medications to lower blood pressure and reduce strain on the cardiovascular system
• Heart failure: Helps improve symptoms and survival in patients with reduced heart function following heart attacks or other cardiac conditions
• Cardiovascular risk reduction: Prescribed for patients over 55 with additional risk factors to prevent heart attacks, strokes, and cardiovascular-related deaths
• Diabetic kidney disease: Helps protect kidney function in patients with diabetes who have protein in their urine
• Post-heart attack treatment: Used in stable patients following myocardial infarction to improve survival and reduce further cardiac events

How it works

Ramipril blocks the angiotensin-converting enzyme, which prevents the conversion of angiotensin I to angiotensin II, a powerful vasoconstrictor. By reducing angiotensin II levels, blood vessels relax and widen, decreasing blood pressure and reducing the workload on the heart. The medication also decreases the breakdown of bradykinin, a substance that helps dilate blood vessels and provides additional cardiovascular protection.

Side effects

Common side effects include:

Submit Your Paper

• Dry, persistent cough
• Dizziness or lightheadedness
• Fatigue or weakness
• Headache
• Nausea
• Elevated potassium levels
• Kidney function changes
• Low blood pressure

Serious side effects requiring immediate medical attention:

• Angioedema (swelling of face, lips, tongue, or throat)
• Severe drop in blood pressure
• Significant kidney function deterioration
• Dangerously high potassium levels
• Severe allergic reactions

Warnings and precautions

• Pregnancy: Ramipril is contraindicated during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the developing fetus including kidney problems and death
• Kidney disease: Patients with severe kidney impairment or those on dialysis require careful monitoring and dose adjustments, as the medication can worsen kidney function
• Liver disease: Those with significant liver impairment may need dose modifications since ramipril is metabolized by the liver
• Angioedema history: Patients with a previous history of angioedema from any cause should avoid ACE inhibitors due to increased risk of recurrence
• Dehydration and surgery: The medication should be used cautiously in patients who are dehydrated or undergoing major surgery due to risk of severe blood pressure drops

Interactions

• Potassium supplements and salt substitutes: Can cause dangerous elevations in blood potassium levels when combined with ramipril
• NSAIDs (ibuprofen, naproxen): May reduce ramipril’s effectiveness and increase risk of kidney problems
• Diuretics: Can cause excessive blood pressure lowering, especially when starting treatment
• Lithium: ACE inhibitors can increase lithium levels in the blood, potentially causing toxicity
• Diabetes medications: Ramipril may enhance blood sugar-lowering effects, requiring glucose monitoring
• Allopurinol: Combination may increase risk of serious allergic reactions
• Potassium-sparing diuretics: Can lead to hyperkalemia when used together
• Gold injections: May cause severe reactions including flushing and low blood pressure

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition being treated. For hypertension, the usual starting dose is 2.5-5 mg once daily, which may be increased to a maintenance dose of 2.5-20 mg daily. For heart failure, treatment typically begins with 1.25-2.5 mg twice daily, gradually increased to a target dose of 5 mg twice daily as tolerated. For cardiovascular risk reduction, the usual dose is 2.5 mg once daily for one week, then 5 mg once daily, with a target of 10 mg once daily. Dosage adjustments are necessary for patients with kidney impairment or those taking certain other medications. All dosing should be individualized and determined by a healthcare provider based on patient response and tolerance.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).